Skip to main content

Peer Review reports

From: Novel tetrahydroisoquinolines as DHFR and CDK2 inhibitors: synthesis, characterization, anticancer activity and antioxidant properties

Original Submission
11 Dec 2023 Submitted Original manuscript
20 Dec 2023 Reviewed Reviewer Report
24 Dec 2023 Reviewed Reviewer Report
4 Jan 2024 Reviewed Reviewer Report
8 Jan 2024 Reviewed Reviewer Report
23 Jan 2024 Author responded Author comments - Eman M. sayed
Resubmission - Version 2
23 Jan 2024 Submitted Manuscript version 2
25 Jan 2024 Reviewed Reviewer Report
27 Jan 2024 Reviewed Reviewer Report
28 Jan 2024 Reviewed Reviewer Report
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
7 Feb 2024 Editorially accepted
16 Feb 2024 Article published 10.1186/s13065-024-01139-w

You can find further information about peer review here.

Back to article page